Clinical Trials Browser

Unknown × Hodgkin Disease × Oxaliplatin × Clear all

NCT04239170 2020-01-23

Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Unknown

Hodgkin Disease